Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy

Michael Hader,Deniz Pinar Savcigil,Andreas Rosin,Philipp Ponfick,Stephan Gekle,Martin Wadepohl,Sander Bekeschus,Rainer Fietkau,Benjamin Frey,Eberhard Schlücker,Udo S. Gaipl

DOI: https://doi.org/10.3390/cancers12051082

2020-04-27

Cancers

Abstract:The treatment of breast cancer by radiotherapy can be complemented by hyperthermia. Little is known about how the immune phenotype of tumor cells is changed thereby, also in terms of a dependence on the heating method. We developed a sterile closed-loop system, using either a warm-water bath or a microwave at 2.45 GHz to examine the impact of ex vivo hyperthermia on cell death, the release of HSP70, and the expression of immune checkpoint molecules (ICMs) on MCF-7 and MDA-MB-231 breast cancer cells by multicolor flow cytometry and ELISA. Heating was performed between 39 and 44 °C. Numerical process simulations identified temperature distributions. Additionally, irradiation with 2 × 5 Gy or 5 × 2 Gy was applied. We observed a release of HSP70 after hyperthermia at all examined temperatures and independently of the heating method, but microwave heating was more effective in cell killing, and microwave heating with and without radiotherapy increased subsequent HSP70 concentrations. Adding hyperthermia to radiotherapy, dynamically or individually, affected the expression of the ICM PD-L1, PD-L2, HVEM, ICOS-L, CD137-L, OX40-L, CD27-L, and EGFR on breast cancer cells. Well-characterized pre-clinical heating systems are mandatory to screen the immune phenotype of tumor cells in clinically relevant settings to define immune matrices for therapy adaption.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the effects of different heating methods (warm - water bath or microwave radiation) on the immunophenotype of breast cancer cells in vitro hyperthermia, especially when used in combination with radiotherapy. Specifically, the study aims to explore the following issues:

1. **Specific effects of hyperthermia on breast cancer cell death and immunophenotype**: including cell death rate, release of heat shock protein 70 (HSP70), and changes in the expression of immune checkpoint molecules (ICMs).
2. **Differences in the effects of different heating methods**: compare the effects of these two heating methods, warm - water bath and microwave radiation, on cells, especially in terms of temperature - dependence and non - thermal effects.
3. **Effects of combined application of hyperthermia and radiotherapy**: evaluate whether the combination of hyperthermia and radiotherapy can enhance the treatment effect, especially the changes in immunophenotype.

Through these studies, the authors hope to provide a standardized heating system for pre - clinical research and a theoretical basis for future multimodal radiotherapy - immunotherapy regimens. This helps to better understand how hyperthermia affects the immunogenicity of breast cancer cells and provides guidance for optimizing treatment strategies.

### Specific research content:
- **Experimental design**: Use a self - developed closed - loop system to perform warm - water bath or microwave heating treatment on two breast cancer cell lines, MCF - 7 and MDA - MB - 231, in the range of 39°C to 44°C.
- **Cell death analysis**: Measure cell apoptosis and necrosis by Annexin V/PI staining and multicolor flow cytometry.
- **HSP70 release detection**: Detect the HSP70 content in cell supernatants by ELISA method.
- **Immune checkpoint molecule expression**: Detect the expression of immune checkpoint molecules such as PD - L1, PD - L2, HVEM, ICOS - L, CD137 - L, OX40 - L, CD27 - L and EGFR by flow cytometry.

### Key findings:
- **Microwave heating is more effective than warm - water bath**: Microwave heating significantly increases the cell death rate and promotes the release of HSP70 at all tested temperatures.
- **The combined use of hyperthermia and radiotherapy has a significant effect**: The combined use of hyperthermia and radiotherapy can significantly increase the cell death rate and dynamically change the expression of immune checkpoint molecules.
- **Temperature - dependence**: As the temperature rises, both the cell death rate and the amount of HSP70 released increase significantly, especially at 44°C.

These results provide new insights into the multimodal treatment of breast cancer, especially the application prospect of hyperthermia as a potential immunomodulatory means.